Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Alfa eCare in connection with the acquisition of 2BRA
Mandate

Vinge advises Main Capital and Alfa eCare in connection with the acquisition of 2BRA

January 02, 2023 Employment and Benefits IT, Telecommunications and Outsourcing Intellectual Property M&A Life Sciences & Health

The Alfa eCare group is a recognized and rapidly growing software provider within the e-health sector that offers solutions to both private and public healthcare providers in the Nordics.

2BRA System AB was founded in 2008 and develops business systems used for labour market measures and initiatives. The company’s services are provided companies that support people in establishing themselves in the labor market and to municipalities, where the company’s system today is used in over 100 municipal operatios. The acquisition of 2BRA is the sixth acquisition by the Alfa eCare group since Main Capital became majority owners of the group in 2020.

Vinge’s team advising Main Capital and Alfa eCare mainly consisted of Filip Öhrner, Linus Adolfsson, Jonna Skog (M&A), Elin Broman (Employment), Lisa Hörnqvist (IT and GDPR), Rebecka Målquist, Johan Gavelin (IP) and Ottilia Pettersson (project assistant).

 

Related

Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

 A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023